Improved biocompatibility of a viscous bioerodible poly(ortho ester) by controlling the environmental pH during degradation.
The poly(ortho ester), POE, used in this investigation, is a viscous bioerodible polymer (8 kDa), which rapidly degrades into a triol and an acidic by-product, acetic acid. In order to improve biocompatibility, we have evaluated the addition of various basic excipients, such as sodium acetate, hydroxyapatite, calcium carbonate and magnesium hydroxide, which buffered and neutralized the acidic degradation product and prolonged the polymer lifetime and drug release. This decrease of POE degradation rate results in a decreased rate of formation of the acidic by-product. Similarly, a POE of higher molecular weight (14 kDa) has been tested. Sodium acetate was too hydrophilic to affect the drug release and the biocompatibility of the polymer, whereas the presence of magnesium hydroxide markedly prolonged the drug release and improved the acceptability of the polymer. The increased molecular weight POE did not improve biocompatibility and a similar but delayed, inflammatory reaction was observed.
Zignani
M
M
School of Pharmacy, Department of Pharmaceutical Technology, University of Geneva, Switzerland.
Le Minh
T
T
Einmahl
S
S
Tabatabay
C
C
Heller
J
J
Anderson
J M
JM
Gurny
R
R
D000818:Animals; D001672:Biocompatible Materials; D003228:Conjunctiva; D005079:Excipients; D005472:Fluorouracil / Q000008:administration & dosage; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D066298:In Vitro Techniques; D011108:Polymers / Q000737:chemistry*; D011817:Rabbits
D001672:Biocompatible Materials; D005079:Excipients; D011108:Polymers; C401107:poly(ortho ester); D005472:Fluorouracil